IBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium
ID: 75A50325RFI00010Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEASPR/ORM-SNSAtlanta, GA, 30341, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

Original Source

https://sam.gov/opp/22073b867ad04ad1b09a06435743e2ed/view
Timeline
    Description

    The Department of Health and Human Services (HHS) is issuing a Request for Information (RFI) for the IBMSC Resilient Industry and Supply Chain Enterprise (RISE) Consortium, aimed at enhancing pandemic preparedness through partnerships with the pharmaceutical and biomanufacturing sectors. The initiative seeks feedback from industry partners on their manufacturing capabilities and insights into challenges faced in ensuring a robust supply chain for essential medicines, personal protective equipment (PPE), and diagnostics during public health emergencies. This effort is critical for strengthening the domestic public health industrial base and aligns with national security objectives outlined in recent executive orders. Interested parties must submit their responses by July 13, 2025, to the designated contacts, Ashia Everett and Annette Wright, via their provided email addresses.

    Point(s) of Contact
    Ashia Everett
    ashia.everett@hhs.gov
    Annette Wright
    annette.wright@hhs.gov
    Files
    Title
    Posted
    amended_IBMSC Consortium RFI_FINAL.pdf
    The U.S. Department of Health and Human Services (HHS) is seeking input through a Request for Information (RFI) to foster partnerships with the pharmaceutical and biomanufacturing sectors. This initiative, known as the Resilient Industry and Supply Chain Enterprise (RISE) Consortium, aligns with governmental objectives to strengthen the domestic public health industrial base as outlined in key executive orders aimed at enhancing national security and pandemic preparedness. HHS aims to establish consortia that will develop reliable manufacturing capabilities for essential medicines, personal protective equipment (PPE), and diagnostics during public health emergencies. Interested companies are invited to participate or lead these consortia by providing details about their manufacturing capabilities and insights on challenges faced in ensuring a robust supply chain. Key objectives include creating agile manufacturing systems, enhancing supply chain resilience, and promoting innovative technology solutions. The response is intended for market research only; no solicitation currently exists, and the government will not fund responses. Interested parties must submit their inputs by July 13, 2025, with specified contact points provided for communication. This initiative reflects the government’s commitment to preparing for future public health threats through collaborative industrial efforts.
    IBMSC Consortium RFI_FINAL.pdf
    The U.S. Department of Health and Human Services (HHS) is issuing a Request for Information (RFI) to gather insights from pharmaceutical and biomanufacturing partners in developing the Resilient Industry and Supply Chain Enterprise (RISE) Consortium. This initiative aims to enhance the domestic public health industrial base in support of national pandemic preparedness goals as outlined in Executive Orders 13944 and 14017. The RFI seeks feedback on establishing consortia for drug, personal protective equipment (PPE), and diagnostic manufacturing, emphasizing the need for robust supply chains and scalable manufacturing during public health emergencies. HHS is interested in partners that can provide manufacturing capabilities, including single-use consumables and diagnostics, while also addressing potential barriers and concerns related to participation in consortia. Respondents are encouraged to discuss their operational capabilities, the feasibility of sustaining production outside emergencies, and transparency regarding supply chain risks. This RFI is a market research step towards forming partnerships that bolster America’s response to public health crises and ultimately enhance national security without soliciting formal proposals at this stage. Responses are due by July 13, 2025, to specified contacts within the government.
    QA_IBMSC Consortium RFI.pdf
    The IBMSC Resilient Industry and Supply Chain Enterprise (RISE) is issuing a Request for Information (RFI) seeking responses from companies interested in joining a consortium focused on enhancing preparedness and response capabilities regarding public health emergencies (PHEs). Responses are due by July 13th at 8:00 AM EST, with a limit of 10 pages for company experience, supplemented by additional pages discussing barriers to consortium participation, prioritization for USG access to funded infrastructures during PHEs, sustainability of capacities amidst fluctuating demands, and data sharing related to supply chain management. The performance location is not geographically restricted, allowing for nationwide participation. The RFI invites both potential consortium leads and interested participants, emphasizing collaboration and information sharing within the industry to optimize supply chain resilience. This initiative aims to strengthen the United States' response framework for future public health challenges.
    Lifecycle
    Title
    Type
    IBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium
    Currently viewing
    Sources Sought
    Similar Opportunities
    Health Care Delivery Solutions (HCDS) Electronic Health Record Follow-on (MHS GENESIS)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking industry input for the Health Care Delivery Solutions (HCDS) Electronic Health Record (EHR) Follow-on (MHS GENESIS) procurement. This initiative aims to modernize the DoD's healthcare management system by enhancing interoperability, optimizing patient care, and leveraging commercial technology advancements while ensuring efficient integration with the Department of Veterans Affairs (VA). The procurement process is critical for maintaining a robust electronic health record system that serves approximately 9.6 million beneficiaries and 194,000 users. Interested parties are encouraged to submit their responses to the Request for Information (RFI) by November 17, 2025, and can direct inquiries to Sonya Edom at sonya.m.edom.civ@health.mil or Gabriela Hurte at gabriela.y.hurte.civ@health.mil. The anticipated timeline includes a draft RFP in Q1 FY26 and contract awards by Q4 FY26.
    Resilient Systems Office (RSO) Mission Office Innovative Solutions Opening (ISO)
    Buyer not available
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Resilient Systems Office (RSO) Mission Office Innovative Solutions Opening (ISO). This opportunity invites submissions that address systemic challenges in healthcare and public health by leveraging innovative technologies to improve care quality, efficacy, and accessibility. Proposals will be evaluated based on scientific merit, alignment with ARPA-H's mission, proposer capabilities, and cost, with a focus on open-source intellectual property and compliance with research regulations. Interested parties must submit solution summaries and proposals via the designated ARPA-H portal, with the closing date for submissions set for March 5, 2029. For further inquiries, proposers can reach out through the same portal.
    Scalable Solutions Office (SSO) Mission Office Innovative Solutions Opening (ISO)
    Buyer not available
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) under the Scalable Solutions Office (SSO). This initiative aims to develop innovative solutions that enhance healthcare access, affordability, and distribution, particularly in underserved communities, while addressing challenges in biomanufacturing and health technology distribution. The solicitation is open until March 5, 2029, and encourages submissions from academia, non-profits, and for-profit entities, with multiple awards anticipated as Other Transactions. Interested parties must submit a Solution Summary for initial feedback before proceeding with a full proposal, adhering to strict guidelines on intellectual property, research security, and cost proposal requirements. For further details, proposers can reach out through the designated submission portals and must ensure compliance with the updated administrative and national policy requirements outlined in the solicitation documents.
    BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
    Buyer not available
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking qualified contractors to support the development of vaccine medical countermeasures for pandemic influenza preparedness and response. The objective of this Sources Sought Notice (SSN) is to refine requirements and establish long-term partnerships with contractors capable of producing vaccines, antigens, and adjuvants necessary for pandemic preparedness and public health emergencies. This initiative is critical for enhancing the U.S. response to influenza viruses with pandemic potential and ensuring rapid regulatory decisions and manufacturing readiness. Interested parties must submit evidence of eligibility, capabilities statements, and requests to participate by email to Laura Saddison at Laura.Saddison@hhs.gov by 3:00 pm EST on December 19, 2025. This SSN/RFI is for information and planning purposes only and does not constitute a solicitation.
    Online Database of Preventive and Travel Health Information-Enterprise and Aerial Route Intelligence Subscription Services-Request for Information
    Buyer not available
    The Department of Homeland Security (DHS), Office of Health Security (OHS), is seeking qualified vendors to provide an enterprise-level online database and alert service for preventive and travel health information, as part of a Request for Information (RFI). The objective is to enhance DHS workforce health readiness and epidemiological monitoring through a subscription service that includes features such as aerial route risk mapping, continuous updates on infectious diseases, vaccination requirements, and access to medical facilities. This service is critical for ensuring timely, evidence-based information for risk assessment and travel planning for up to 1,000 users, thereby supporting the health and safety of DHS personnel. Interested parties must submit their capability statements by December 10, 2025, and can contact Mark Namoco at mark.namoco@hq.dhs.gov or Brendan Benisek at Brendan.Benisek@hq.dhs.gov for further information.
    Proactive Health Office (PHO) Mission Office Innovative Solutions Opening (ISO)
    Buyer not available
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the healthspan and health outcomes of Americans by focusing on proactive health measures. The Proactive Health Office (PHO) seeks proposals that address population-level improvements in disease prevention, early detection methods, and system-level innovations for effective health delivery, emphasizing revolutionary advances rather than incremental improvements. This opportunity is critical for fostering advancements in public health and requires adherence to specific administrative and national policy guidelines, including intellectual property rights and research security measures. Interested parties must submit a Solution Summary by March 5, 2029, and can find further details and submission links at https://solutions.arpa-h.gov, with inquiries directed to the same site.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) targeting chemical, biological, radiological, nuclear threats, and emerging infectious diseases, including pandemic influenza. The initiative aims to enhance public health preparedness by fostering partnerships with private organizations, government laboratories, and academic institutions to expedite the development of life-saving MCMs critical for national health security. Proposals will be evaluated based on scientific merit, technological maturity, and regulatory compliance, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties should direct inquiries to BARDA-BAA@hhs.gov for further information.
    Domestic Capability Building Activity – Onshoring the Manufacturing of Viral Hemorrhagic Fever Vaccine Candidates
    Buyer not available
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking to enhance domestic biopharmaceutical manufacturing capabilities through a contract focused on onshoring the production of viral hemorrhagic fever vaccine candidates. The primary objective is to transfer the manufacturing processes for Vesicular Stomatitis Virus (VSV) Delta G based vaccine candidates from international sites to domestic Contract Development and Manufacturing Organizations (CDMOs) in the United States, thereby strengthening national health security preparedness against threats like the Marburg and Sudan viruses. This initiative is critical as it addresses the current limited domestic capacity for live viral vector manufacturing, ensuring a robust response to infectious disease challenges. Interested parties must be product sponsors or technology owners with BARDA-sponsored monovalent filovirus vaccine candidates and should prepare for a technology transfer demonstration, as the scope does not include procurement of investigational or licensed products.
    Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO)
    Buyer not available
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO). This initiative aims to gather innovative solutions that address future healthcare challenges, focusing on groundbreaking research in areas such as maternal/fetal medicine, genetic therapies, chronic diseases, and mental health, while excluding proposals for incremental advances or clinical trials. Proposers are required to submit a Solution Summary for initial feedback, followed by a detailed proposal that adheres to updated administrative and national policy requirements, including compliance with ethical research guidelines and research security disclosures. Interested parties should submit their proposals via the designated ARPA-H portal, with specific deadlines and further details available through the provided links.
    A--Biologic Specimen and Data Repositories Information Coordinating Center (BioLIN
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC). This opportunity aims to gather insights on the capabilities and qualifications of potential contractors who can support the management and coordination of biologic specimen and data repositories. The services are critical for advancing health research and ensuring the integrity and accessibility of biological data for various studies. Interested parties can reach out to Natalie E. Bruning at natalie.bruning@nih.gov or by phone at +1 301 827 7528 for further details regarding this sources sought notice.